Navigation Links
New Hereditary Bone Joint Disorder Identified

Researchers from Case Western Reserve University and University of California have found evidence for a new hereditary joint disorder which has been reported in Journal of Arthritis & Rheumatism//. The disease is found to cause extensive bubbling of the cartilage leading to tear off from the bone. This results was from a case study in which the father and all his three children were suffering from the disorder.

Degenerative disorders of the hips was found in all the three children’s and in their factors causing exposure of the cartilage leading to bubbling and tearing off by which the bones are exposed at an early age, the father of the 3 children’s had pain in the hip and knees from the age of 10 and by the age of 40 he had a hip replacement. All the 3 children’s had multiple arthroscopic procedures in the knees, hips and shoulders. The exposing of the cartilage leads to vulnerability of various complications at an early age leading to fragility of the bone, which is highly increased.

"Further studies elucidating the mechanisms leading to the delamination of cartilage from the bone in the family may provide insights into cartilage-bone interaction in other forms of joint degeneration," wrote the researchers, from Case Western Reserve University in Cleveland and the University of California, San Diego
'"/>




Page: 1

Related medicine news :

1. Urinary Incontinence May Be Hereditary
2. Childhood Wheezing Could Be Hereditary
3. New Study May Help Prevent Hereditary Deafness
4. Hereditary Non-BRCA Breast Cancer Can Trigger New Cancers
5. Scientists Claim Encouraging Progress On Hereditary Diseases
6. Gene Therapy Shows Promise Against Hereditary Lung Disease
7. Gene Therapy for Hereditary Immunodeficiency Diseases
8. Risk Of Soft Tissue Sarcomas In Hereditary Retinoblastoma Survivors
9. New Treatment For Hip Joints
10. Joint replacement surgery outcomes may be affected by obesity and diabetes
11. New combined therapy for Knee Joint pain
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: New Hereditary Bone Joint Disorder Identified

(Date:9/2/2015)... , ... September 03, 2015 , ... ... and frequently listed among the most influential leaders in healthcare, will offer the ... Coalition, to take place October 15-16, 2015, in Palm Harbor, Florida, at the ...
(Date:9/2/2015)... ... September 03, 2015 , ... One can hardly argue against the fact ... do laptops and personal computers. These devices are being used as GPS, to make ... of mobile dating apps, STD positive singles can now join the prestigious social ranks ...
(Date:9/2/2015)... ... ... Sara Bleich, Ph.D., associate professor of health and policy ... recognized scholar on obesity prevention and control, has been selected for the prestigious ... graduate of Garrison Forest School, an all-girls’ independent school in Owings Mills, Md., ...
(Date:9/2/2015)... DC (PRWEB) , ... September 03, 2015 , ... ... of nominations to determine who among America’s policymakers, public servants, activists, corporate executives, ... the nation’s health care. This year, that process led the magazine to tap ...
(Date:9/2/2015)... ... September 02, 2015 , ... The CRISPR-Cas9 system ... complex of the Cas9 nuclease with either a chimeric single guide RNA (sgRNA) or ... of any given guide RNA (sgRNA or crRNA) to create a break in the ...
Breaking Medicine News(10 mins):Health News:ACO Coalition Meeting to Feature Leapfrog’s Leah Binder 2Health News:ACO Coalition Meeting to Feature Leapfrog’s Leah Binder 3Health News:Herpes-datingsites.com Recently Added Reviews of 5 STD Dating Apps for STD Positive Singles 2Health News:Dr. Sara Bleich, Garrison Forest Graduate, Selected for 2015-16 Class of White House Fellows 2Health News:NLN CEO Dr. Beverly Malone Named One of 100 Most Influential in Health Care 2Health News:NLN CEO Dr. Beverly Malone Named One of 100 Most Influential in Health Care 3Health News:GE Healthcare Webinar Discusses Improvements to CRISPR-Cas9 Gene Editing 2Health News:GE Healthcare Webinar Discusses Improvements to CRISPR-Cas9 Gene Editing 3Health News:GE Healthcare Webinar Discusses Improvements to CRISPR-Cas9 Gene Editing 4
... , , , ANNAPOLIS, ... PIP ), a biodefense company developing medical countermeasures against biological ... agreements for the issuance of 2-year, 10% unsecured senior convertible ... private placement of approximately $19.3 million. , , ...
... July 27 Health Robotics today announced,that it has ... to market,implement, and support its I.V. Workflow Engine and ... North America. One of,its software modules (OncoCube) has already ... University of Colorado Hospital [Denver], in,addition to all-digital ...
... , , , ... reveals that adults living in the country,s fifth largest city are ... and complex conditions. Many commonly used therapy classes including drugs to ... have experienced increases in adults 20 and older. , ...
... , Trinitas Comprehensive Cancer Center in Elizabeth, ... chemotherapy program in place , , LOS ... a variety of cancers--along with projections from the National Comprehensive Cancer Network ... by 2013--raise questions for both clinicians and patients with regard to the ...
... COLD SPRING HARBOR, N.Y., July 27 AccuVein LLC, ... illumination device, today announced that its quality system has received ... to customers around the globe AccuVein,s commitment to the quality ... and delivery procedures. , , ...
... , FRANKLIN, Mass., July 27 PLC ... innovative cardiac and vascular medical device-based technologies, today announced it ... capabilities provided by RenalGuard(R) from the Canadian Intellectual Property Office ... patent for RenalGuard in Canada. , , ...
Cached Medicine News:Health News:PharmAthene, Inc. Announces $19.3 Million Private Placement of Convertible Notes and Common Stock Warrants 2Health News:PharmAthene, Inc. Announces $19.3 Million Private Placement of Convertible Notes and Common Stock Warrants 3Health News:PharmAthene, Inc. Announces $19.3 Million Private Placement of Convertible Notes and Common Stock Warrants 4Health News:Health Robotics Announces American Joint Venture With i.v.SOFT 2Health News:Health Robotics Announces American Joint Venture With i.v.SOFT 3Health News:Chronic and Complex Diseases on the Rise in Philadelphia: Adults Using More Medications to Treat Chronic Conditions 2Health News:Chronic and Complex Diseases on the Rise in Philadelphia: Adults Using More Medications to Treat Chronic Conditions 3Health News:Chronic and Complex Diseases on the Rise in Philadelphia: Adults Using More Medications to Treat Chronic Conditions 4Health News:Oral Chemotherapy Offers Patients a More Convenient, Less Invasive Treatment Option 2Health News:Oral Chemotherapy Offers Patients a More Convenient, Less Invasive Treatment Option 3Health News:AccuVein Achieves Quality System Milestone 2Health News:Canada Grants PLC Systems First Patent for RenalGuard(R) 2
(Date:9/2/2015)... Miss. , Sept. 2, 2015   Gulf Coast Tattoo ... removal services with the cutting-edge Astanza Duality laser in ... unwanted ink erase their tattoo regret and take back control of ... but extends its services to Biloxi ... region. "With tattoo regret being as prevalent as it ...
(Date:9/2/2015)... -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX ) announced today ... Neurocrine Biosciences, will be presenting at the Baird 2015 ... . The live presentation takes place on ... presentation will be webcast and may be accessed on ... Listeners are encouraged to visit the website approximately ...
(Date:9/2/2015)... , Sept. 2, 2015  ArmaGen, Inc., ... revolutionary therapies to treat severe neurological disorders, announced ... in its multi-center Phase 1/2a clinical trial of ... (MPS I). AGT-181 is an ... of MPS I. The most severe form of ...
Breaking Medicine Technology:Gulf Coast Tattoo Removal Delivers Unrivaled Tattoo Removal Results To Biloxi And Gulfport With Astanza Duality 2ArmaGen Announces First Patient Dosed in Phase 1/2a Clinical Trial of AGT-181 for the Treatment of Hurler Syndrome 2ArmaGen Announces First Patient Dosed in Phase 1/2a Clinical Trial of AGT-181 for the Treatment of Hurler Syndrome 3ArmaGen Announces First Patient Dosed in Phase 1/2a Clinical Trial of AGT-181 for the Treatment of Hurler Syndrome 4
... China , May 6 /PRNewswire-Asia-FirstCall/ -- China Pharma,Holdings, Inc. (NYSE AMEX: ... in China , today announced,that it will participate in the following investor ... ... 2010 ,in New York City . Management is scheduled to present at ...
... Obtaining access to busy physicians grew still more difficult for pharmaceutical ... reps fell nearly 20 percent, the number of prescribers refusing to see ... that were nearly impossible to complete topped 8 million. , ... These are among the findings of the ...
Cached Medicine Technology:China Pharma Holdings, Inc. Announces May Investor Conference Participation 2China Pharma Holdings, Inc. Announces May Investor Conference Participation 3China Pharma Holdings, Inc. Announces May Investor Conference Participation 4The Doctor Won't See You (Mr. Pharma Rep), Now 2The Doctor Won't See You (Mr. Pharma Rep), Now 3The Doctor Won't See You (Mr. Pharma Rep), Now 4The Doctor Won't See You (Mr. Pharma Rep), Now 5The Doctor Won't See You (Mr. Pharma Rep), Now 6
RCB™ Rotator Cuff Buttress is a completely resorbable plate that will alleviate suture migration in open or mini-Open rotator cuff repairs....
... LactoSorb copolymer is an absorbable co-polymer ... acid and 18% glycolic acid. Unlike ... as 100% poly-L-lactic acid (PLLA) or ... is substantially amorphous (without crystallinity), meaning ...
... an absorbable co-polymer synthesized from all-natural ... glycolic acid. Unlike the homopolymers in ... acid (PLLA) or 100% poly-glycolic acid ... (without crystallinity), meaning that its degradation ...
... Medicine™ AnchorSew™ 3 mm is a resorbable repair ... Medicine ArthroSew suturing device to attach soft tissue ... implanted into a prepared hole in the bone, ... soft tissue anchors are made of a resorbable ...
Medicine Products: